Insider · CIK 0001780878
Linda Llewelyn
Files at HCAT (Health Catalyst, Inc.). First filing Oct 17, 2024, latest Feb 20, 2025.
Linda Llewelyn files SEC Form 4 as officer at HCAT (Health Catalyst, Inc.). Since Oct 17, 2024, Linda Llewelyn has reported 0 open-market buys worth $0 and 5 open-market sells worth $146k, the latest filed on Feb 20, 2025.
A track record needs three past buys with six months of prices behind them; Linda Llewelyn has 0, so none is measured yet.
The newest scored trade: sold $35k of HCAT on Feb 18, 2025, filed Feb 20, 2025, scored 9 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCAT: Health Catalyst, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 9Weak | Health Catalyst, Inc. | $35k 6,441 shares | -7% | 0% from low-40% from high | |
| 16Weak | Health Catalyst, Inc. | $37k 6,442 shares | -7% | 0% from low-36% from high | |
| 17Weak | Health Catalyst, Inc. | $51k 6,442 shares | -6% | +7% from low-13% from high | |
| 3Weak | Health Catalyst, Inc. | $12k 1,365 shares | -1% | - | |
| 0Weak | Health Catalyst, Inc. | $11k 1,324 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 2, 2025 | HCAT Health Catalyst, Inc | 2,965 0.00% of outstanding | $11k | Jun 2, 2025 | $34k |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | 7,525 0.01% of outstanding | $34k | Mar 3, 2025 | $193k |
| Feb 18, 2025 | HCAT HEALTH CATALYST INC | 6,641 0.01% of outstanding | $36k | Feb 18, 2025 | $158k |
| Jan 15, 2025 | HCAT HEALTH CATALYST INC | 6,442 0.01% of outstanding | $38k | Jan 15, 2025 | $132k |
| Dec 16, 2024 | HCAT HEALTH CATALYST, INC. | 6,442 0.01% of outstanding | $51k | Dec 16, 2024 | $92k |
| Dec 2, 2024 | HCAT Health Catalyst, Inc. | 7,766 0.01% of outstanding | $70k | Dec 2, 2024 | $45k |
| Nov 15, 2024 | HCAT HEALTH CATALYST INC | 1,365 0.00% of outstanding | $12k | Nov 15, 2024 | $34k |
| Oct 15, 2024 | HCAT HEALTH CATALYST INC | 1,324 0.00% of outstanding | $11k | Oct 15, 2024 | $32k |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -13,836 | $1.66 | $23k | 329,651 | Mar 5, 2026 |
| Feb 25, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +191,500 | $0.00 | $0 | 334,763 | Feb 27, 2026 |
| Feb 25, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +13,195 | $0.00 | $0 | 347,958 | Feb 27, 2026 |
| Feb 26, 2026 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -4,471 | $1.75 | $7,814 | 343,487 | Feb 27, 2026 |
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -9,762 | $2.90 | $28k | 143,263 | Dec 3, 2025 |
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -2,854 | $3.36 | $9,597 | 153,025 | Sep 4, 2025 |
| Jun 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -2,965 | $3.63 | $11k | 155,879 | Jun 3, 2025 |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -7,525 | $4.58 | $34k | 158,844 | Mar 4, 2025 |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +69,000 | $0.00 | $0 | 154,819 | Feb 24, 2025 |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +11,750 | $0.00 | $0 | 166,369 | Feb 24, 2025 |
| Feb 18, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -6,441 | $5.43 | $35k | 85,819 | Feb 20, 2025 |
| Jan 15, 2025 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -6,442 | $5.80 | $37k | 92,260 | Jan 17, 2025 |
| Dec 16, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -6,442 | $7.88 | $51k | 98,702 | Dec 18, 2024 |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -7,766 | $8.97 | $70k | 105,144 | Dec 3, 2024 |
| Nov 15, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -1,365 | $8.50 | $12k | 112,910 | Nov 18, 2024 |
| Oct 15, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -1,324 | $8.16 | $11k | 114,275 | Oct 17, 2024 |
Questions about Linda Llewelyn
Answered from the filings on this page, as of the latest one.
Is Linda Llewelyn buying or selling?
Not in the last 12 months. Linda Llewelyn's latest open-market trade on SEC Form 4 was sold $35k of HCAT on Feb 18, 2025.
How did Linda Llewelyn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Linda Llewelyn has 0.
Where does Linda Llewelyn file Form 4?
Linda Llewelyn has filed Form 4 at HCAT (Health Catalyst, Inc.) as Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.